Evidence map›Paper›PMID 34255504›Full record

ArticleJournal of the American Chemical Society2021

Peptoid Residues Make Diverse, Hyperstable Collagen Triple-Helices.

Julian L Kessler, Grace Kang, Zhao Qin, Helen Kang, Frank G Whitby, Thomas E Cheatham, Christopher P Hill, Yang Li, S Michael Yu

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cationic Peptoids for Systemic In Vivo Cartilage-Targeting.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Around the collagen triple helix: an introduction to studying associated genetic and acquired diseases.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Bioprinting of gelatin-based materials for orthopedic application.Frontiers in bioengineering and biotechnology · 2024
    Review
  14. Article
  15. Recent advances in the development of therapeutic peptides.Trends in pharmacological sciences · 2023
    Review
  16. Article
  17. The Chemistry and Biology of Collagen Hybridization.Journal of the American Chemical Society · 2023
    Review
  18. Collagen Molecular Damage is a Hallmark of Early Atherosclerosis Development.Journal of cardiovascular translational research · 2023
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Julian L KesslerDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States.ORCID 0000-0002-4497-235X
Grace KangDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States.
Zhao QinDepartment of Civil & Environmental Engineering, College of Engineering & Computer Science, Syracuse University, Syracuse, New York 13244, United States.ORCID 0000-0001-5696-8553
Helen KangDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States.
Frank G WhitbyDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah 84112, United States.
Thomas E CheathamDepartment of Medicinal Chemistry, College of Pharmacy, L. S. Skaggs Pharmacy Research Institute, University of Utah, Salt Lake City, Utah 84112, United States.ORCID 0000-0003-0298-3904
Christopher P HillDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah 84112, United States.
Yang LiDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States.ORCID 0000-0003-4729-7860
S Michael YuDepartment of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States.ORCID 0000-0002-5171-2644

Funding

Targeting Collagen Mechanical Damage using Collagen Hybridizing PeptidesR01AR071358 · NIAMS · UNIVERSITY OF UTAH · PI WEISS, JEFFREY A., YU, MICHAEL S · 2018 to 2022
$1.9M
In situ imaging of collagen degradation activity in multiple myeloma and lung fibrosis mouse modelR21OD026618 · OD · UNIVERSITY OF UTAH · PI YOON, DONGHOON, YU, MICHAEL S · 2019 to 2020
$430k
Sustained Intravitreal Delivery of Ranibizumab Mediated by ECM BindingR21EY029430 · NEI · UNIVERSITY OF UTAH · PI YU, MICHAEL S · 2018 to 2019
$419k
NEI NIH HHS R21 EY029430NIAMS NIH HHS R01 AR071358NIH HHS R21 OD026618
6 · The paper itself

Abstract

As the only ribosomally encoded N-substituted amino acid, proline promotes distinct secondary protein structures. The high proline content in collagen, the most abundant protein in the human body, is crucial to forming its hallmark structure: the triple-helix. For over five decades, proline has been considered compulsory for synthetic designs aimed at recapitulating collagen's structure and properties. Here we describe that N-substituted glycines (N-glys), also known as peptoid residues, exhibit a general triple-helical propensity similar to or greater than proline, enabling synthesis of stable triple-helical collagen mimetic peptides (CMPs) with unprecedented side chain diversity. Supported by atomic-resolution crystal structures as well as circular dichroism and computational characterizations spanning over 30 N-gly-containing CMPs, we discovered that N-glys stabilize the triple-helix primarily by sterically preorganizing individual chains into the polyproline-II helix. We demonstrated that N-glys with exotic side chains including a "click"-able alkyne and a photosensitive side chain enable CMPs for functional applications including the spatiotemporal control of cell adhesion and migration. The structural principles uncovered in this study open up opportunities for a new generation of collagen-mimetic therapeutics and materials.

Indexed as

CollagenGlycineMolecular StructurePeptidesCollagenGlycinePeptides

Identifiers

PMID34255504
PMCPMC9209468

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.